Key Points
- Director Steven Orlando sold 702 shares for about $159,586, reducing his direct ownership by 3.84% to 17,569 shares.
- Molina beat quarterly estimates, reporting EPS of $0.89 versus $0.79 expected and revenue of $11.08 billion versus $10.86 billion; revenue nevertheless fell 3.4% year over year.
- Analysts’ consensus rating was Hold, with an average price target of $213.88; the stock opened at $233.08.
Molina Healthcare, Inc (NYSE:MOH - Get Free Report) Director Steven Orlando sold 702 shares of the business's stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $227.33, for a total value of $159,585.66. Following the completion of the sale, the director directly owned 17,569 shares of the company's stock, valued at $3,993,960.77. The trade was a 3.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Molina Healthcare Stock Up 11.3%
MOH stock opened at $233.08 on Tuesday. The stock's 50 day simple moving average is $203.21 and its 200 day simple moving average is $185.92. The company has a market cap of $12.17 billion, a P/E ratio of 104.93, a price-to-earnings-growth ratio of 12.38 and a beta of 0.75. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The firm had revenue of $11.08 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter last year, the firm posted $1.84 earnings per share. The company's revenue for the quarter was down 3.4% compared to the same quarter last year. On average, research analysts expect that Molina Healthcare, Inc will post 5.30 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. Sanford C. Bernstein reiterated an "outperform" rating on shares of Molina Healthcare in a report on Tuesday, October 27th. JPMorgan Chase & Co. lifted their price target on shares of Molina Healthcare from $220.00 to $225.00 and gave the company a "neutral" rating in a research report on Tuesday, October 27th. Royal Bank Of Canada boosted their price target on shares of Molina Healthcare from $218.00 to $222.00 and gave the company a "sector perform" rating in a research note on Friday, October 23rd. Weiss Ratings upgraded shares of Molina Healthcare from a "sell (d)" rating to a "sell (d+)" rating in a report on Wednesday, October 21st. Finally, Jefferies Financial Group restated a "hold" rating and set a $220.00 price objective on shares of Molina Healthcare in a report on Friday, October 23rd. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $213.88.
Check Out Our Latest Analysis on Molina Healthcare
Key Molina Healthcare News
These are some of the MOH news items that stood out recently:
- Positive Sentiment: Investors rotated into defensive healthcare names amid weakness in riskier parts of the market, lifting Molina alongside the sector. Recent earnings results and reaffirmed 2026 adjusted earnings guidance may also be supporting sentiment. Sector news
- Positive Sentiment: Zacks Research raised several estimates for 2027 and 2028 earnings, including its FY2027 and FY2028 forecasts, although it maintained a Hold rating. Molina Healthcare estimates
- Negative Sentiment: Zacks Research cut its Q4 2026 EPS estimate to $0.52 from $0.69, tempering the positive impact of its upward revisions to later-period estimates.
Hedge Funds Weigh In On Molina Healthcare
A number of hedge funds have recently added to or reduced their stakes in MOH. BlackRock Inc. bought a new stake in Molina Healthcare during the 2nd quarter worth approximately $1,503,052,000. Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 23.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company's stock valued at $185,929,000 after purchasing an additional 267,121 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Molina Healthcare by 11.9% in the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company's stock valued at $289,810,000 after purchasing an additional 135,247 shares in the last quarter. Manning & Napier Advisors LLC bought a new position in shares of Molina Healthcare in the second quarter valued at approximately $152,339,000. Finally, Maverick Capital Ltd. purchased a new position in shares of Molina Healthcare during the first quarter valued at approximately $86,081,000. Institutional investors and hedge funds own 98.50% of the company's stock.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].